Variable | n | DSS | LRFS | ||
n | p Value | n | p Value | ||
Gender | 0.878 | 0.346 | |||
Male | 95 | 45 | 30 | ||
Female | 29 | 14 | 7 | ||
Age (years) | 0.996 | 0.755 | |||
<60 | 98 | 48 | 29 | ||
≥60 | 26 | 11 | 8 | ||
Primary tumour (T) | 0.065 | 0.027* | |||
T1–T2 | 80 | 32 | 19 | ||
T3–T4 | 44 | 27 | 18 | ||
Nodal status (N) | 0.002* | 0.023* | |||
N0–N1 | 56 | 18 | 12 | ||
N2–N3 | 68 | 41 | 25 | ||
Stage | 0.007* | 0.005* | |||
I–II | 38 | 10 | 3 | ||
III–IV | 86 | 49 | 32 | ||
Histological grade | 0.157 | 0.900 | |||
Keratinising/non-keratinising | 47 | 40 | 15 | ||
Undifferentiated | 77 | 39 | 22 | ||
EMP2 expression level | 0.002* | 0.005* | |||
Positive (>5% tumour cells) | 63 | 21 | 13 | ||
Negative (≤5% tumour cells) | 61 | 38 | 24 |
↵* Statistically significant.
DSS, disease-specific survival; LRFS, local recurrence-free survival.